Occupational exposures to irritants and sensitizers, asthma and asthma control in the NutriNet-Santé cohort

Elsevier

Available online 13 September 2022

The Journal of Allergy and Clinical Immunology: In PracticeAbstractBackground

The role of chronic occupational exposures to irritants in asthma remains not well-defined. Few studies have examined their associations with asthma and its control.

Objective

To study the associations of occupational exposures with asthma and its control, with specific interest for irritants, including disinfectants/cleaning products (DCP) and solvents.

Methods

Analyses included 4469 adults (3792 with neither asthma nor respiratory symptoms, 677 with current asthma; 75.9% women, mean age 54 years) of a case-control study (2018) from the French NutriNet-Santé cohort. Current asthma was defined by ever asthma with symptoms, medication or asthma attacks in the past 12 months, adult-onset asthma by age at first asthma attack > 16 years, and uncontrolled asthma was defined by an Asthma Control Test (ACT) score <20. Ever/current exposures were assessed with the Occupational Asthma-specific Job-Exposure Matrix (OAsJEM). Associations were evaluated by multinomial logistic regressions adjusted for sex, age, smoking status and body mass index.

Results

Ever exposures to sensitizers (High Molecular Weight [HMW]: OR 1.53, 95%CI 1.18-2.00, and Low Molecular Weight [LMW]: 1.42, 1.09-1.87), irritants (1.32, 1.03-1.68), and DCP (1.43, 1.10-1.85) were associated with current adult-onset asthma. Significant associations between ever exposures and uncontrolled adult-onset asthma were observed for HMW (2.69, 1.52-4.78) and LMW (2.27, 1.24-4.37) sensitizers, irritants (2.32, 1.36-3.95), and DCP (2.59, 1.48-4.54). Results were similar for current exposures, with higher ORs. No association was observed with solvents.

Conclusion

Occupational exposures to both sensitizers and irritants were associated with current adult-onset asthma and uncontrolled asthma. Irritant and sensitizing agents should be carefully considered in asthma management.

View full text

© 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology

留言 (0)

沒有登入
gif